Quadruple Valve Replacement for Carcinoid Heart Disease
Abstract Introduction: Carcinoid heart disease most frequently involves the tricuspid or, more rarely, the pulmonary valve and presents with right heart failure as 5-HT is metabolized by the lung. Left-sided valve involvement is quite rare. We describe our experience of 3 patients presenting with heart failure secondary to carcinoid heart disease affecting all four cardiac valves. There are only four previous isolated case reports in the literature. Methods: All three patients underwent quadruple valve replacement during a single operation. Right ventricular outflow tract reconstruction with a pericardial patch was performed in all patients. For 24 hours prior to surgery, all patients received intravenous octreotide, which continued in intensive care for at least 24 hours. Results: Mean cross-clamp and bypass times were 175 (range 164-197 minutes) and 210 (range 195-229 minutes) minutes, respectively. Mean intensive treatment unit (ITU) and inpatient stays were 2.3 (range 2-3 days) and 12 (range 9-16 days) days, respectively. One patient was reopened for bleeding 4 hours postoperatively from a ventricular pacing wire site. None required a permanent pacemaker postoperatively. There were no other complications in any patient. The quality of life was excellent at 6-16 months clinic follow-up as they were in NYHA 1. Postoperative echocardiography showed no paravalvular leaks and well-functioning prostheses in all cases. Conclusion: Surgery to replace all four valves is feasible with excellent medium-term survival and a very low rate of complications. Patients with carcinoid heart disease should always be considered for surgery irrespective of the extent of valvular involvement.
Main Authors: | Mujtaba,Syed Saleem, Clark,Stephen |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Cirurgia Cardiovascular
2018
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382018000400398 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thrombocytopenia After Aortic Valve Replacement: Comparison Between Sutureless Perceval S Valve and Perimount Magna Ease Bioprosthesis
by: Mujtaba,Syed Saleem, et al.
Published: (2018) -
Aortic Valve Replacement with a Conventional Stented Bioprosthesis versus Sutureless Bioprosthesis: a Study of 763 Patients
by: Mujtaba,Syed Saleem, et al.
Published: (2018) -
Valvular Disorders in Carcinoid Heart Disease
by: Yuan,Shi-Min
Published: (2016) -
Early Clinical Results of Perceval Sutureless Aortic Valve in 139 Patients: Freeman Experience
by: Mujtaba,Syed Saleem, et al.
Published: (2018) -
Update in Heart Valve Replacement [electronic resource] : Proceedings of the Second European Symposium on the St. Jude Medical Heart Valve /
by: Horstkotte, D. editor., et al.
Published: (1986)